Icosapent ethyl/Rosuvastatin

二十碳五烯酸乙酯/瑞舒伐他汀

Report date: 2024/03/20 11:42:03

Base Information

Drug NameIcosapent ethyl/Rosuvastatin
Drug Alias NameRosuvastatin/Icosapent ethyl瑞舒伐他汀+二十碳五烯酸乙酯Ethyl eicosapentaenoic acid/rosuvastatin - Amarin瑞舒伐他汀/二十碳五烯酸乙酯二十碳五烯酸乙酯+瑞舒伐他汀 +[11] 
ClassificationSmall molecules
Mechanisms of ActionHMG-CoA reductase inhibitorsPeroxisome proliferator-activated receptor α agonists
TargetsHMG-CoA reductasePeroxisome proliferator-activated receptor α
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Icosapent ethylRosuvastatin Calcium
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmarin Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmarin Pharma
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A